|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
180,310,000 |
Market
Cap: |
41.24(B) |
Last
Volume: |
799,597 |
Avg
Vol: |
864,930 |
52
Week Range: |
$191.51 - $228.9 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TIVDAK, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers, and TUKYSA®, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
39,326 |
449,967 |
Total Sell Value |
$0 |
$0 |
$8,245,949 |
$81,866,696 |
Total People Sold |
0 |
0 |
7 |
8 |
Total Sell Transactions |
0 |
0 |
18 |
69 |
End Date |
2024-03-31 |
2023-12-29 |
2023-06-30 |
2022-06-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Berger Franklin M |
officerTitle |
|
2005-12-30 |
4 |
A |
$4.71 |
$47,294 |
D/D |
10,000 |
61,692 |
|
- |
|
Berger Franklin M |
officerTitle |
|
2005-12-29 |
4 |
A |
$4.86 |
$48,835 |
D/D |
10,000 |
51,692 |
|
- |
|
Berger Franklin M |
officerTitle |
|
2005-12-27 |
4 |
A |
$4.84 |
$57,422 |
D/D |
11,592 |
41,692 |
|
- |
|
Berger Franklin M |
officerTitle |
|
2005-12-23 |
4 |
A |
$5.05 |
$46,269 |
D/D |
9,100 |
30,100 |
|
- |
|
Siegall Clay B |
President and CEO |
|
2005-09-13 |
4 |
S |
$5.97 |
$435,810 |
D/D |
(73,000) |
1,086,500 |
|
- |
|
Siegall Clay B |
President and CEO |
|
2005-09-09 |
4 |
S |
$5.91 |
$11,820 |
D/D |
(2,000) |
1,159,500 |
|
- |
|
Siegall Clay B |
President and CEO |
|
2005-09-08 |
4 |
S |
$5.98 |
$11,960 |
D/D |
(2,000) |
1,161,500 |
|
- |
|
Siegall Clay B |
President and CEO |
|
2005-09-07 |
4 |
S |
$6.00 |
$120,000 |
D/D |
(20,000) |
1,163,500 |
|
- |
|
Siegall Clay B |
President and CEO |
|
2005-08-02 |
4 |
S |
$5.93 |
$53,402 |
D/D |
(9,000) |
1,183,500 |
|
- |
|
Siegall Clay B |
President and CEO |
|
2005-08-01 |
4 |
S |
$5.90 |
$251,411 |
D/D |
(42,500) |
1,192,500 |
|
- |
|
Siegall Clay B |
President and CEO |
|
2005-07-29 |
4 |
S |
$5.95 |
$308,933 |
D/D |
(51,500) |
1,235,000 |
|
- |
|
Siegall Clay B |
President and CEO |
|
2005-07-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
1,286,500 |
|
- |
|
Lippman Marc E |
Director |
|
2005-05-10 |
4 |
A |
$5.66 |
$5,665 |
I/I |
1,000 |
8,000 |
|
- |
|
Carroll Tim |
CFO |
|
2005-05-05 |
4 |
S |
$5.30 |
$217,320 |
D/D |
(40,000) |
62,861 |
|
- |
|
Baker Felix |
Director |
|
2005-05-04 |
4 |
B |
$4.79 |
$3,247 |
I/I |
678 |
26,933 |
2.17 |
- |
|
Baker Felix |
Director |
|
2005-05-04 |
4 |
B |
$4.79 |
$4,541 |
I/I |
948 |
49,807 |
2.17 |
- |
|
Baker Felix |
Director |
|
2005-05-04 |
4 |
B |
$4.79 |
$5,853 |
I/I |
1,222 |
45,090 |
2.17 |
- |
|
Baker Felix |
Director |
|
2005-05-04 |
4 |
B |
$4.79 |
$30,199 |
I/I |
6,305 |
234,861 |
2.25 |
- |
|
Baker Felix |
Director |
|
2005-05-04 |
4 |
B |
$4.79 |
$31,741 |
I/I |
6,627 |
353,150 |
2.25 |
- |
|
Baker Felix |
Director |
|
2005-05-04 |
4 |
B |
$4.79 |
$34,682 |
I/I |
7,241 |
388,638 |
2.25 |
- |
|
Baker Felix |
Director |
|
2005-05-04 |
4 |
B |
$4.79 |
$6,935 |
I/I |
1,448 |
76,887 |
2.17 |
- |
|
Baker Felix |
Director |
|
2005-05-04 |
4 |
B |
$4.79 |
$2,543 |
I/I |
531 |
19,561 |
2.17 |
- |
|
Carroll Tim |
CFO |
|
2005-05-04 |
4 |
S |
$4.60 |
$126,045 |
D/D |
(26,500) |
102,861 |
|
- |
|
Carroll Tim |
CFO |
|
2005-05-03 |
4 |
S |
$4.45 |
$89,000 |
D/D |
(20,000) |
129,361 |
|
- |
|
Lippman Marc E |
Director |
|
2005-05-03 |
4 |
A |
$4.26 |
$4,312 |
I/I |
1,000 |
7,000 |
|
- |
|
1805 Records found
|
|
Page 65 of 73 |
|
|